Subscribe to RSS - Alere

Alere

Arriva Medical in ‘midst’ of ALJ appeal

Acquisition by Abbott Laboratories moves forward
 - 
04/21/2017

CORAL SPRINGS, Fla. – Arriva Medical, a provider of diabetes testing supplies, remains confident that it will get its Medicare billing status reinstated.

Abbott Labs, Alere deal moves forward

 - 
04/18/2017

ABBOTT PARK, Ill., and WALTHAM, Mass. – Abbott Laboratories has agreed to buy Alere, but at a lower price than it previously offered.

Arriva gets day in court

 - 
01/11/2017

WALTHAM Mass. – CMS has agreed not to terminate Arriva Medical’s mail-order contract while the provider appeals to have its license reinstated.

In brief: CMS releases nat’l health expenditures, OIG says two brands dominate mail-order market for diabetes supplies

 - 
12/09/2016

WASHINGTON – Per-capita healthcare spending grew by 5% and overall healthcare spending grew by 5.8% in 2015, according to a recent study by the Office of the Actuary at CMS.

Abbott wants to ditch Alere

 - 
12/08/2016

WALTHAM, Mass. – Abbott Laboratories has sued Alere in an effort to terminate its buyout of the company, according to news reports.

CMS revokes Arriva’s billing privileges

 - 
11/22/2016

CORAL SPRINGS, Fla. – Arriva Medical’s contract for CMS’s national mail-order program for diabetes supplies is in question.